Growth momentum Biotech Dental has a strong revenue range and a sizable global footprint with over 2 million implants sold, indicating expanding adoption opportunities for complementary products and services in dental implants, software, and accessories.

Acquisition leverage Recent ownership by Henry Schein suggests access to broader distribution channels, potential cross-sell of implant systems, software platforms like LaGalaxy, and integration with Schein’s customer base.

R&D focus Investing over ten percent of turnover in R&D signals a pipeline of innovative solutions; sales reps can position advanced intraoral scanners, 3D imaging, and open platform software to future-ready clinics.

Open platform LaGalaxy software platform indicates a strategy around integrated clinical and administrative workflow; opportunity to upsell hardware, imaging, and practice-management integrations.

3D imaging push Partnerships to develop high-precision 3D intraoral scanners point to a growing market for digital dentistry tools; targeting clinics investing in digital workflow and patient outcomes could yield high-CPQ deals.